Insilico targeting of virus entry facilitator NRP1 to block SARS-CoV2 entry

Insilico targeting of virus entry facilitator NRP1 to block SARS-CoV2 entry

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Nousheen Bibi, Maleeha Shah, Shahzad Khan, Muhammad Shahzad Chohan, Mohammad Amjad Kamal
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11798527/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Insilico targeting of virus entry facilitator NRP1 to block SARS-CoV2 entry.
by: Nousheen Bibi, et al.
Published: (2025-01-01)

Correction: Insilico targeting of virus entry facilitator NRP1 to block SARS-CoV2 entry.
by: Nousheen Bibi, et al.
Published: (2025-01-01)

Replication Features of SARS-CoV‑2 and Advantages of Targeting S Protein with Aptamers to Block Viral Entry
by: Jun Zheng, et al.
Published: (2025-04-01)

Berbamine prevents SARS-CoV-2 entry and transmission
by: Srikanth Sadhu, et al.
Published: (2024-12-01)

Virus Entry by Endocytosis
by: Anthony V. Nicola, et al.
Published: (2013-01-01)

GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus
by: Danying Chen, et al.
Published: (2019-01-01)

Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection
by: Kuo‐Yen Huang, et al.
Published: (2020-11-01)

Entry Inhibitors of SARS-CoV-2 Targeting the Transmembrane Domain of the Spike Protein
by: Kristin V. Lyles, et al.
Published: (2025-07-01)

Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry
by: Weiyi Chen, et al.
Published: (2025-08-01)

Host susceptibilities and entry processes of SARS-CoV-2 Omicron variants using pseudotyped viruses carrying spike protein
by: Alexandria Zabiegala, et al.
Published: (2025-05-01)

Dengue Virus Entry as Target for Antiviral Therapy
by: Marijke M. F. Alen, et al.
Published: (2012-01-01)

FDA-approved drug repurposing screen identifies inhibitors of SARS-CoV-2 pseudovirus entry
by: Manisha Singh, et al.
Published: (2025-03-01)

The Renin–Angiotensin System Modulates SARS-CoV-2 Entry via ACE2 Receptor
by: Sophia Gagliardi, et al.
Published: (2025-07-01)

AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells
by: Galindo-Hernández Octavio, et al.
Published: (2022-09-01)

Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.
by: Chaitra Prabhakara, et al.
Published: (2021-07-01)

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
by: Tanay M Desai, et al.
Published: (2014-04-01)

Neuropilin-1: A Conserved Entry Receptor for SARS-CoV-2 and a Potential Therapeutic Target
by: Vivany Maydel Sierra-Sánchez, et al.
Published: (2025-07-01)

Characterization of SARS‐CoV‐2 Entry Genes in Skeletal Muscle and Impacts of In Vitro Versus In Vivo Infection
by: Salyan Bhattarai, et al.
Published: (2025-02-01)

SARS-CoV-2 Omicron variations reveal mechanisms controlling cell entry dynamics and antibody neutralization.
by: Enya Qing, et al.
Published: (2024-12-01)

Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants
by: Mohamed Mahdi, et al.
Published: (2025-05-01)

Special Issue: Research on Herpes Virus Fusion and Entry
by: Doina Atanasiu, et al.
Published: (2024-11-01)

Integrin beta 1 facilitates non-enveloped hepatitis E virus cell entry through the recycling endosome
by: Rebecca Fu, et al.
Published: (2025-06-01)

Rapavir, a novel inhibitor of sodium taurocholate cotransporting polypeptide, potently blocks hepatitis B virus entry
by: Jia He, et al.
Published: (2025-04-01)

Low Antibody-Dependent Enhancement of Viral Entry Activity Supports the Safety of Inactivated SARS-CoV-2 Vaccines
by: Xiaofang Peng, et al.
Published: (2025-04-01)

Cellular sialoglycans are differentially required for endosomal and cell-surface entry of SARS-CoV-2 in lung cell lines.
by: Kimberley C Siwak, et al.
Published: (2024-12-01)

Diphyllin elicits a doubled-pronged attack on the entry of SARS-CoV-2 by inhibiting cathepsin L and furin
by: Binli Mao, et al.
Published: (2024-12-01)

Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry.
by: Wenlin Ren, et al.
Published: (2021-03-01)

CD1d facilitates African swine fever virus entry into the host cells via clathrin-mediated endocytosis
by: Xin Chen, et al.
Published: (2023-12-01)

Structural and mechanistic studies of measles virus illuminate paramyxovirus entry.
by: Richard K Plemper, et al.
Published: (2011-06-01)

Design and hardware implementation of LED block cipher for vehicles keyless entry systems
by: Ayoub Mhaouch, et al.
Published: (2025-06-01)

Comments on “Pythagoras theorem for the point of needle entry: Ultrasound-guided regional blocks”
by: Wasimul Hoda, et al.
Published: (2025-01-01)

Green Synthesis of Tetrahydropyrazino[2,1-a:5,4-a′]diisoquinolines as SARS-CoV‑2 Entry Inhibitors
by: Sowndarya Palla, et al.
Published: (2024-12-01)

miR-24-3p Is Antiviral Against SARS-CoV-2 by Downregulating Critical Host Entry Factors
by: Parrish Evers, et al.
Published: (2024-11-01)

Text Entry by Gazing and Smiling
by: Outi Tuisku, et al.
Published: (2013-01-01)

The Evolving Role of Zika Virus Envelope Protein in Viral Entry and Pathogenesis
by: Ashkan Roozitalab, et al.
Published: (2025-06-01)

mGem: The complexity of viral entry—one virus, many receptors
by: Terence S. Dermody, et al.
Published: (2025-03-01)

Entry Efficiency, Protease Dependence, and Antibody-Mediated Neutralization of SARS-CoV-2 Sublineages KP.3.1.1 and XEC
by: Prerna Arora, et al.
Published: (2025-04-01)

From Entry to Outbreak in a High School Setting: Clinical and Wastewater Surveillance of a Rare SARS-CoV-2 Variant
by: Sven Sachse, et al.
Published: (2025-03-01)

Commentary: Beyond distal anastomosis new entry: Distal re-entry tears as wellCentral Message
by: Thomas M. Beaver, MD, MPH, et al.
Published: (2021-10-01)

COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation
by: Mohamed M. Aboudounya, et al.
Published: (2021-01-01)